nodes	percent_of_prediction	percent_of_DWPC	metapath
Perhexiline—CYP2B6—malignant glioma	0.84	1	CbGaD
Perhexiline—CYP3A4—Temozolomide—malignant glioma	0.0646	1	CbGbCtD
Perhexiline—CPT2—retina—malignant glioma	0.00208	0.135	CbGeAlD
Perhexiline—CPT1A—telencephalon—malignant glioma	0.00201	0.13	CbGeAlD
Perhexiline—CPT2—medulla oblongata—malignant glioma	0.0015	0.0973	CbGeAlD
Perhexiline—CPT2—midbrain—malignant glioma	0.00137	0.0889	CbGeAlD
Perhexiline—CPT2—spinal cord—malignant glioma	0.00134	0.0868	CbGeAlD
Perhexiline—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00116	0.0618	CcSEcCtD
Perhexiline—CPT1A—cerebellum—malignant glioma	0.00112	0.0725	CbGeAlD
Perhexiline—CPT2—central nervous system—malignant glioma	0.00109	0.0704	CbGeAlD
Perhexiline—CPT2—cerebellum—malignant glioma	0.00106	0.0688	CbGeAlD
Perhexiline—Liver injury—Temozolomide—malignant glioma	0.00103	0.0553	CcSEcCtD
Perhexiline—Gait disturbance—Carmustine—malignant glioma	0.000923	0.0493	CcSEcCtD
Perhexiline—CPT1A—brain—malignant glioma	0.000909	0.0589	CbGeAlD
Perhexiline—CYP2D6—Oxidation by Cytochrome P450—POR—malignant glioma	0.000908	0.0147	CbGpPWpGaD
Perhexiline—Gait disturbance—Temozolomide—malignant glioma	0.000892	0.0476	CcSEcCtD
Perhexiline—CYP3A4—Liver X Receptor Pathway—CYP2B6—malignant glioma	0.000877	0.0142	CbGpPWpGaD
Perhexiline—CPT1A—FOXA2 and FOXA3 transcription factor networks—F2—malignant glioma	0.000864	0.014	CbGpPWpGaD
Perhexiline—CPT2—brain—malignant glioma	0.000862	0.0559	CbGeAlD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—RUNX3—malignant glioma	0.000819	0.0133	CbGpPWpGaD
Perhexiline—CPT1A—Circadian Clock—HIF1A—malignant glioma	0.000785	0.0127	CbGpPWpGaD
Perhexiline—CPT2—PPARA activates gene expression—NCOR1—malignant glioma	0.000772	0.0125	CbGpPWpGaD
Perhexiline—CYP2D6—Xenobiotics—CYP2B6—malignant glioma	0.000771	0.0125	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—MYB—malignant glioma	0.000756	0.0123	CbGpPWpGaD
Perhexiline—CPT2—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NCOR1—malignant glioma	0.000756	0.0122	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—SOX2—malignant glioma	0.00073	0.0118	CbGpPWpGaD
Perhexiline—CPT1A—PPAR Alpha Pathway—MYC—malignant glioma	0.000693	0.0112	CbGpPWpGaD
Perhexiline—CYP2D6—Xenobiotics—CYP2C18—malignant glioma	0.000668	0.0108	CbGpPWpGaD
Perhexiline—Diplopia—Carmustine—malignant glioma	0.000654	0.0349	CcSEcCtD
Perhexiline—Diplopia—Temozolomide—malignant glioma	0.000632	0.0338	CcSEcCtD
Perhexiline—Ataxia—Carmustine—malignant glioma	0.000615	0.0328	CcSEcCtD
Perhexiline—Ataxia—Temozolomide—malignant glioma	0.000594	0.0317	CcSEcCtD
Perhexiline—CPT2—Metabolism—RTEL1—malignant glioma	0.000594	0.00963	CbGpPWpGaD
Perhexiline—CYP3A4—Oxidation by Cytochrome P450—POR—malignant glioma	0.000593	0.00961	CbGpPWpGaD
Perhexiline—CPT1A—AMPK Signaling—PIK3CG—malignant glioma	0.000577	0.00935	CbGpPWpGaD
Perhexiline—Muscular weakness—Carmustine—malignant glioma	0.000577	0.0308	CcSEcCtD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—YWHAE—malignant glioma	0.000568	0.0092	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—NTRK2—malignant glioma	0.000568	0.0092	CbGpPWpGaD
Perhexiline—Muscular weakness—Temozolomide—malignant glioma	0.000557	0.0298	CcSEcCtD
Perhexiline—CPT2—PPARA activates gene expression—PPARG—malignant glioma	0.000553	0.00896	CbGpPWpGaD
Perhexiline—CPT2—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—malignant glioma	0.000541	0.00877	CbGpPWpGaD
Perhexiline—CPT1A—PPARA activates gene expression—NCOR1—malignant glioma	0.000535	0.00867	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—PML—malignant glioma	0.000531	0.00861	CbGpPWpGaD
Perhexiline—CPT1A—AMPK Signaling—AKT2—malignant glioma	0.000528	0.00855	CbGpPWpGaD
Perhexiline—CPT1A—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NCOR1—malignant glioma	0.000524	0.00849	CbGpPWpGaD
Perhexiline—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—malignant glioma	0.000521	0.00844	CbGpPWpGaD
Perhexiline—CPT1A—AMPK Signaling—PIK3CD—malignant glioma	0.000507	0.00822	CbGpPWpGaD
Perhexiline—CYP3A4—Xenobiotics—CYP2B6—malignant glioma	0.000504	0.00816	CbGpPWpGaD
Perhexiline—Weight decreased—Temozolomide—malignant glioma	0.000494	0.0264	CcSEcCtD
Perhexiline—Neuropathy peripheral—Carmustine—malignant glioma	0.000494	0.0264	CcSEcCtD
Perhexiline—CPT1A—Circadian rythm related genes—TOP2A—malignant glioma	0.000486	0.00788	CbGpPWpGaD
Perhexiline—Neuropathy peripheral—Temozolomide—malignant glioma	0.000477	0.0255	CcSEcCtD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—GJA1—malignant glioma	0.000467	0.00756	CbGpPWpGaD
Perhexiline—CPT1A—AMPK Signaling—PIK3CB—malignant glioma	0.000442	0.00716	CbGpPWpGaD
Perhexiline—Hepatitis—Temozolomide—malignant glioma	0.000437	0.0234	CcSEcCtD
Perhexiline—CYP3A4—Xenobiotics—CYP2C18—malignant glioma	0.000437	0.00708	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000425	0.00688	CbGpPWpGaD
Perhexiline—Flushing—Carmustine—malignant glioma	0.00042	0.0224	CcSEcCtD
Perhexiline—CYP2D6—brainstem—malignant glioma	0.000416	0.027	CbGeAlD
Perhexiline—CPT1A—Metabolism—RTEL1—malignant glioma	0.000412	0.00667	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000411	0.00666	CbGpPWpGaD
Perhexiline—CYP3A4—Irinotecan Pathway—BCHE—malignant glioma	0.000409	0.00663	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—HES1—malignant glioma	0.000407	0.00659	CbGpPWpGaD
Perhexiline—Flushing—Temozolomide—malignant glioma	0.000406	0.0217	CcSEcCtD
Perhexiline—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000399	0.00647	CbGpPWpGaD
Perhexiline—CYP2B6—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000394	0.00638	CbGpPWpGaD
Perhexiline—CPT1A—PPARA activates gene expression—PPARG—malignant glioma	0.000383	0.00621	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—NTRK1—malignant glioma	0.000378	0.00612	CbGpPWpGaD
Perhexiline—CPT1A—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—malignant glioma	0.000375	0.00608	CbGpPWpGaD
Perhexiline—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—malignant glioma	0.000373	0.00605	CbGpPWpGaD
Perhexiline—CYP2D6—telencephalon—malignant glioma	0.00037	0.0239	CbGeAlD
Perhexiline—Tremor—Carmustine—malignant glioma	0.000369	0.0197	CcSEcCtD
Perhexiline—CYP3A4—Tryptophan metabolism—ASMT—malignant glioma	0.000363	0.00588	CbGpPWpGaD
Perhexiline—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—malignant glioma	0.000361	0.00585	CbGpPWpGaD
Perhexiline—Tremor—Temozolomide—malignant glioma	0.000357	0.019	CcSEcCtD
Perhexiline—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.000346	0.00561	CbGpPWpGaD
Perhexiline—Convulsion—Carmustine—malignant glioma	0.000341	0.0182	CcSEcCtD
Perhexiline—CPT2—Metabolism—COX8A—malignant glioma	0.000341	0.00553	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.000341	0.00553	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—NCOR1—malignant glioma	0.00033	0.00535	CbGpPWpGaD
Perhexiline—Convulsion—Temozolomide—malignant glioma	0.00033	0.0176	CcSEcCtD
Perhexiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.00033	0.00534	CbGpPWpGaD
Perhexiline—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000324	0.00524	CbGpPWpGaD
Perhexiline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00032	0.00519	CbGpPWpGaD
Perhexiline—CYP2D6—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000316	0.00512	CbGpPWpGaD
Perhexiline—CPT1A—FOXA2 and FOXA3 transcription factor networks—AKT1—malignant glioma	0.000316	0.00511	CbGpPWpGaD
Perhexiline—Anorexia—Carmustine—malignant glioma	0.000306	0.0164	CcSEcCtD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000305	0.00494	CbGpPWpGaD
Perhexiline—Hyperhidrosis—Temozolomide—malignant glioma	0.0003	0.016	CcSEcCtD
Perhexiline—Anorexia—Temozolomide—malignant glioma	0.000296	0.0158	CcSEcCtD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000294	0.00477	CbGpPWpGaD
Perhexiline—Insomnia—Carmustine—malignant glioma	0.000291	0.0155	CcSEcCtD
Perhexiline—CPT2—Metabolism—ASMT—malignant glioma	0.00029	0.0047	CbGpPWpGaD
Perhexiline—Paraesthesia—Carmustine—malignant glioma	0.000289	0.0154	CcSEcCtD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000285	0.00461	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000284	0.00459	CbGpPWpGaD
Perhexiline—CYP2B6—central nervous system—malignant glioma	0.000283	0.0183	CbGeAlD
Perhexiline—Insomnia—Temozolomide—malignant glioma	0.000281	0.015	CcSEcCtD
Perhexiline—Decreased appetite—Carmustine—malignant glioma	0.000279	0.0149	CcSEcCtD
Perhexiline—Paraesthesia—Temozolomide—malignant glioma	0.000279	0.0149	CcSEcCtD
Perhexiline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000277	0.0045	CbGpPWpGaD
Perhexiline—CYP2D6—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000274	0.00444	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—BCAN—malignant glioma	0.000273	0.00442	CbGpPWpGaD
Perhexiline—Decreased appetite—Temozolomide—malignant glioma	0.00027	0.0144	CcSEcCtD
Perhexiline—CPT1A—AMPK Signaling—PIK3CA—malignant glioma	0.00027	0.00437	CbGpPWpGaD
Perhexiline—Fatigue—Temozolomide—malignant glioma	0.000268	0.0143	CcSEcCtD
Perhexiline—Gastrointestinal pain—Carmustine—malignant glioma	0.000263	0.014	CcSEcCtD
Perhexiline—CPT1A—AMPK Signaling—TP53—malignant glioma	0.000261	0.00423	CbGpPWpGaD
Perhexiline—CYP2D6—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000259	0.0042	CbGpPWpGaD
Perhexiline—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—malignant glioma	0.000259	0.00419	CbGpPWpGaD
Perhexiline—Abdominal pain—Carmustine—malignant glioma	0.000254	0.0136	CcSEcCtD
Perhexiline—Gastrointestinal pain—Temozolomide—malignant glioma	0.000254	0.0136	CcSEcCtD
Perhexiline—Urticaria—Temozolomide—malignant glioma	0.000247	0.0132	CcSEcCtD
Perhexiline—Abdominal pain—Temozolomide—malignant glioma	0.000246	0.0131	CcSEcCtD
Perhexiline—CYP2B6—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000245	0.00397	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—PPARG—malignant glioma	0.000237	0.00384	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—COX8A—malignant glioma	0.000236	0.00383	CbGpPWpGaD
Perhexiline—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000232	0.00376	CbGpPWpGaD
Perhexiline—Asthenia—Carmustine—malignant glioma	0.000231	0.0123	CcSEcCtD
Perhexiline—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000225	0.00364	CbGpPWpGaD
Perhexiline—CYP2B6—brain—malignant glioma	0.000224	0.0145	CbGeAlD
Perhexiline—CYP3A4—Tryptophan metabolism—CYP2C18—malignant glioma	0.000224	0.00364	CbGpPWpGaD
Perhexiline—Asthenia—Temozolomide—malignant glioma	0.000223	0.0119	CcSEcCtD
Perhexiline—CYP3A4—Irinotecan Pathway—APC—malignant glioma	0.000222	0.0036	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000221	0.00358	CbGpPWpGaD
Perhexiline—CPT1A—AMPK Signaling—AKT1—malignant glioma	0.00022	0.00357	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—IDH2—malignant glioma	0.00022	0.00356	CbGpPWpGaD
Perhexiline—CYP3A4—central nervous system—malignant glioma	0.000213	0.0138	CbGeAlD
Perhexiline—Dizziness—Carmustine—malignant glioma	0.000213	0.0114	CcSEcCtD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000212	0.00344	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000212	0.00343	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000211	0.00343	CbGpPWpGaD
Perhexiline—CYP2D6—central nervous system—malignant glioma	0.00021	0.0136	CbGeAlD
Perhexiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000209	0.00339	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000207	0.00336	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CYP2B6—malignant glioma	0.000207	0.00335	CbGpPWpGaD
Perhexiline—CYP3A4—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000206	0.00335	CbGpPWpGaD
Perhexiline—Dizziness—Temozolomide—malignant glioma	0.000205	0.011	CcSEcCtD
Perhexiline—CYP2D6—cerebellum—malignant glioma	0.000205	0.0133	CbGeAlD
Perhexiline—Vomiting—Carmustine—malignant glioma	0.000204	0.0109	CcSEcCtD
Perhexiline—Rash—Carmustine—malignant glioma	0.000203	0.0108	CcSEcCtD
Perhexiline—Dermatitis—Carmustine—malignant glioma	0.000202	0.0108	CcSEcCtD
Perhexiline—Headache—Carmustine—malignant glioma	0.000201	0.0108	CcSEcCtD
Perhexiline—CPT1A—Metabolism—ASMT—malignant glioma	0.000201	0.00326	CbGpPWpGaD
Perhexiline—Vomiting—Temozolomide—malignant glioma	0.000197	0.0105	CcSEcCtD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000197	0.00318	CbGpPWpGaD
Perhexiline—Rash—Temozolomide—malignant glioma	0.000196	0.0105	CcSEcCtD
Perhexiline—Dermatitis—Temozolomide—malignant glioma	0.000196	0.0105	CcSEcCtD
Perhexiline—Headache—Temozolomide—malignant glioma	0.000195	0.0104	CcSEcCtD
Perhexiline—Nausea—Carmustine—malignant glioma	0.000191	0.0102	CcSEcCtD
Perhexiline—CPT1A—Metabolism—BCAN—malignant glioma	0.000189	0.00306	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—IDH1—malignant glioma	0.000189	0.00306	CbGpPWpGaD
Perhexiline—Nausea—Temozolomide—malignant glioma	0.000185	0.00985	CcSEcCtD
Perhexiline—CPT2—Metabolism—SPHK1—malignant glioma	0.000183	0.00296	CbGpPWpGaD
Perhexiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000181	0.00294	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.00018	0.00291	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CYP2C18—malignant glioma	0.000179	0.0029	CbGpPWpGaD
Perhexiline—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000179	0.0029	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—CYP2C18—malignant glioma	0.000172	0.00279	CbGpPWpGaD
Perhexiline—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.00017	0.00276	CbGpPWpGaD
Perhexiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.00017	0.00275	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—CYP2C18—malignant glioma	0.00017	0.00275	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000169	0.00274	CbGpPWpGaD
Perhexiline—CYP2D6—brain—malignant glioma	0.000167	0.0108	CbGeAlD
Perhexiline—CPT1A—Circadian rythm related genes—PTEN—malignant glioma	0.000162	0.00263	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000154	0.0025	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000154	0.00249	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—IDH2—malignant glioma	0.000152	0.00247	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000149	0.00241	CbGpPWpGaD
Perhexiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000147	0.00238	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—GSTT1—malignant glioma	0.000145	0.00235	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000144	0.00233	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CYP2B6—malignant glioma	0.000143	0.00232	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—GSTT1—malignant glioma	0.000139	0.00225	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—CYP2B6—malignant glioma	0.000138	0.00223	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—CYP2B6—malignant glioma	0.000136	0.0022	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PTGS1—malignant glioma	0.000136	0.0022	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000135	0.00219	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—IDH1—malignant glioma	0.000131	0.00212	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—PTGS1—malignant glioma	0.00013	0.00211	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—SPHK1—malignant glioma	0.000127	0.00205	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—BCHE—malignant glioma	0.000126	0.00205	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—SLC5A5—malignant glioma	0.000125	0.00202	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CYP2C18—malignant glioma	0.000124	0.00201	CbGpPWpGaD
Perhexiline—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000122	0.00198	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—CYP2C18—malignant glioma	0.000119	0.00194	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000118	0.00191	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—CYP2C18—malignant glioma	0.000118	0.00191	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000117	0.0019	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000117	0.00189	CbGpPWpGaD
Perhexiline—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000111	0.00181	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—TP53—malignant glioma	0.000111	0.0018	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000107	0.00173	CbGpPWpGaD
Perhexiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000105	0.00171	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000103	0.00167	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000102	0.00165	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—GSTP1—malignant glioma	0.0001	0.00163	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GSTT1—malignant glioma	0.0001	0.00163	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CAT—malignant glioma	9.78e-05	0.00158	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—RTEL1—malignant glioma	9.74e-05	0.00158	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—GSTT1—malignant glioma	9.66e-05	0.00157	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—GSTP1—malignant glioma	9.64e-05	0.00156	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—GSTP1—malignant glioma	9.5e-05	0.00154	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PTGS1—malignant glioma	9.42e-05	0.00153	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	9.38e-05	0.00152	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—NCOR1—malignant glioma	9.23e-05	0.0015	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—PTGS1—malignant glioma	9.05e-05	0.00147	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	9.01e-05	0.00146	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	8.89e-05	0.00144	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—BCHE—malignant glioma	8.75e-05	0.00142	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—SLC5A5—malignant glioma	8.65e-05	0.0014	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8.18e-05	0.00132	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.1e-05	0.00131	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	7.81e-05	0.00127	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	7.7e-05	0.00125	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CAV1—malignant glioma	7.53e-05	0.00122	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.19e-05	0.00117	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.07e-05	0.00114	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GSTP1—malignant glioma	6.96e-05	0.00113	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PIK3CG—malignant glioma	6.86e-05	0.00111	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CAT—malignant glioma	6.78e-05	0.0011	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—RTEL1—malignant glioma	6.77e-05	0.0011	CbGpPWpGaD
Perhexiline—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	6.76e-05	0.0011	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—GSTP1—malignant glioma	6.7e-05	0.00109	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PPARG—malignant glioma	6.62e-05	0.00107	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—GSTP1—malignant glioma	6.61e-05	0.00107	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—NCOR1—malignant glioma	6.4e-05	0.00104	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—GSTT1—malignant glioma	6.32e-05	0.00102	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PIK3CD—malignant glioma	6.03e-05	0.000977	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—PTGS1—malignant glioma	5.92e-05	0.000959	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—COX8A—malignant glioma	5.6e-05	0.000907	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PIK3CB—malignant glioma	5.25e-05	0.000851	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CAV1—malignant glioma	5.22e-05	0.000845	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PTGS2—malignant glioma	5.21e-05	0.000843	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.98e-05	0.000808	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ASMT—malignant glioma	4.76e-05	0.000771	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PIK3CG—malignant glioma	4.75e-05	0.00077	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PPARG—malignant glioma	4.59e-05	0.000743	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PTEN—malignant glioma	4.54e-05	0.000736	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—BCAN—malignant glioma	4.47e-05	0.000725	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—RTEL1—malignant glioma	4.43e-05	0.000717	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—GSTP1—malignant glioma	4.38e-05	0.00071	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	4.32e-05	0.0007	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PIK3CD—malignant glioma	4.18e-05	0.000677	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—COX8A—malignant glioma	3.89e-05	0.00063	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PIK3CB—malignant glioma	3.64e-05	0.00059	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PTGS2—malignant glioma	3.61e-05	0.000585	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—IDH2—malignant glioma	3.61e-05	0.000584	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ASMT—malignant glioma	3.31e-05	0.000536	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—PIK3CA—malignant glioma	3.2e-05	0.000519	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PTEN—malignant glioma	3.15e-05	0.00051	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—BCAN—malignant glioma	3.11e-05	0.000504	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—IDH1—malignant glioma	3.1e-05	0.000502	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—SPHK1—malignant glioma	3e-05	0.000486	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CYP2C18—malignant glioma	2.94e-05	0.000476	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—AKT1—malignant glioma	2.62e-05	0.000424	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—COX8A—malignant glioma	2.54e-05	0.000412	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—IDH2—malignant glioma	2.51e-05	0.000406	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GSTT1—malignant glioma	2.38e-05	0.000385	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CYP2B6—malignant glioma	2.36e-05	0.000382	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PTGS1—malignant glioma	2.23e-05	0.000361	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—PIK3CA—malignant glioma	2.22e-05	0.00036	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ASMT—malignant glioma	2.16e-05	0.00035	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—IDH1—malignant glioma	2.16e-05	0.000349	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—SPHK1—malignant glioma	2.09e-05	0.000338	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—BCHE—malignant glioma	2.07e-05	0.000336	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—SLC5A5—malignant glioma	2.05e-05	0.000332	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CYP2C18—malignant glioma	2.04e-05	0.000331	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—BCAN—malignant glioma	2.03e-05	0.000329	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—AKT1—malignant glioma	1.81e-05	0.000294	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GSTT1—malignant glioma	1.65e-05	0.000268	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GSTP1—malignant glioma	1.65e-05	0.000267	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—IDH2—malignant glioma	1.64e-05	0.000266	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CAT—malignant glioma	1.6e-05	0.00026	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PTGS1—malignant glioma	1.55e-05	0.000251	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.54e-05	0.00025	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—NCOR1—malignant glioma	1.51e-05	0.000245	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—BCHE—malignant glioma	1.44e-05	0.000233	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—SLC5A5—malignant glioma	1.42e-05	0.00023	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—IDH1—malignant glioma	1.41e-05	0.000228	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—SPHK1—malignant glioma	1.36e-05	0.000221	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.34e-05	0.000216	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CAV1—malignant glioma	1.23e-05	0.0002	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GSTP1—malignant glioma	1.15e-05	0.000186	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PIK3CG—malignant glioma	1.12e-05	0.000182	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CAT—malignant glioma	1.11e-05	0.000181	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PPARG—malignant glioma	1.09e-05	0.000176	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GSTT1—malignant glioma	1.08e-05	0.000175	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—NCOR1—malignant glioma	1.05e-05	0.000171	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PTGS1—malignant glioma	1.01e-05	0.000164	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PIK3CD—malignant glioma	9.89e-06	0.00016	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—BCHE—malignant glioma	9.41e-06	0.000153	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—SLC5A5—malignant glioma	9.3e-06	0.000151	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PIK3CB—malignant glioma	8.62e-06	0.00014	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CAV1—malignant glioma	8.58e-06	0.000139	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PTGS2—malignant glioma	8.54e-06	0.000138	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PIK3CG—malignant glioma	7.82e-06	0.000127	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PPARG—malignant glioma	7.54e-06	0.000122	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GSTP1—malignant glioma	7.49e-06	0.000121	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PTEN—malignant glioma	7.45e-06	0.000121	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CAT—malignant glioma	7.29e-06	0.000118	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—NCOR1—malignant glioma	6.88e-06	0.000112	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PIK3CD—malignant glioma	6.87e-06	0.000111	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PIK3CB—malignant glioma	5.99e-06	9.7e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PTGS2—malignant glioma	5.93e-06	9.62e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CAV1—malignant glioma	5.61e-06	9.09e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—PIK3CA—malignant glioma	5.25e-06	8.51e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PTEN—malignant glioma	5.18e-06	8.39e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PIK3CG—malignant glioma	5.11e-06	8.28e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PPARG—malignant glioma	4.93e-06	7.99e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PIK3CD—malignant glioma	4.49e-06	7.28e-05	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—AKT1—malignant glioma	4.29e-06	6.95e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PIK3CB—malignant glioma	3.92e-06	6.34e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PTGS2—malignant glioma	3.88e-06	6.29e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—PIK3CA—malignant glioma	3.65e-06	5.92e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PTEN—malignant glioma	3.38e-06	5.48e-05	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—AKT1—malignant glioma	2.98e-06	4.83e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—PIK3CA—malignant glioma	2.39e-06	3.87e-05	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—AKT1—malignant glioma	1.95e-06	3.16e-05	CbGpPWpGaD
